UnitedHealth Group (UNH) vs S&P 500: Which Is the Better Investment?

Quick Answer

For most long-term investors, the S&P 500 (via ETFs like VOO or SPY) remains the superior core investment due to its inherent diversification, lower volatility, and consistent historical compounding. However, UnitedHealth Group (UNH) presents a compelling satellite position for investors seeking targeted exposure to the healthcare sector, dividend growth, and aggressive share repurchases.

While the S&P 500 has delivered robust, steady gains—returning 23% in 2024, 16% in 2025, and roughly 11% to 13% in the first half of 2026 [3, 10]—UNH has experienced significant volatility. After a challenging 2025 where the stock dropped 33%, UNH has rebounded sharply in 2026, up over 26% year-to-date as of July [4, 10]. Ultimately, choosing between the two depends on your risk tolerance: the S&P 500 offers a smoother ride, while UNH requires the stomach for single-stock volatility and regulatory headwinds.

Current Stock Price & Valuation

As of July 2026, UnitedHealth Group is trading near $418 per share [9]. The company's valuation presents an interesting dichotomy for analysts. On a trailing basis, UNH looks relatively expensive, carrying a price-to-earnings (P/E) ratio of roughly 31.9 [10]. However, markets are forward-looking. The stock trades at a much more reasonable forward P/E of 23.22 [9], reflecting strong anticipated earnings growth.

Financially, UnitedHealth remains a juggernaut. Over the last twelve months (LTM) ending in mid-2026, the company generated a staggering $449.6 billion in total revenues and $16.6 billion in consolidated net income [1]. The company's LTM diluted earnings per share (EPS) stands at $17.51 [1], with full-year 2026 Zacks Consensus Estimates projecting earnings of $18.32 per share [9]. Furthermore, UNH offers a dividend yield of approximately 3.0% and a robust free cash flow yield of 6.6% [3].

Detailed Analysis

Historical Returns Comparison

When comparing UNH to the broader market, the divergence in recent years is stark. The S&P 500 has been on a historic run, posting returns of 27% in 2021, 24% in 2023, 23% in 2024, and 16% in 2025 [3].

Conversely, UNH has seen wild swings. After a massive 45% return in 2021, the stock cooled off, returning 7% in 2022, 1% in 2023, and -2% in 2024 [3]. The real shock came in 2025, when UNH shares plummeted 33% [4]. However, 2026 has marked a massive turnaround, with UNH surging over 26% year-to-date by July [10]. Over a 5-year and 10-year horizon, the S&P 500 has provided a much more consistent upward trajectory, whereas UNH has trailed 57% of its managed healthcare peers over the last five years [4].

Volatility and Risk

Single-stock risk is the primary differentiator here. UNH is highly susceptible to regulatory news and sector-specific shocks. For example, in May 2025, UNH suffered a sharp selloff, falling 23% in a single week (including an 18% drop in one day) [6]. Historically, during severe market shocks, UNH has experienced maximum drawdowns as deep as 72% [10].

The S&P 500, by contrast, spreads its risk across 500 large-cap U.S. companies. Its maximum drawdown during the brutal 2022 bear market was limited to 25% [3].

Diversification and Concentration Risk

Investing in an S&P 500 index fund like SPY or VOO provides instant diversification across technology, healthcare, financials, and consumer goods. Interestingly, by owning the S&P 500, you already own UnitedHealth Group; UNH currently makes up about 0.55% of the S&P 500 index [4]. Buying individual shares of UNH concentrates your capital into the managed healthcare space, exposing you heavily to U.S. Medicare/Medicaid policy changes and medical cost inflation.

Fees and Tax Efficiency

From a cost perspective, S&P 500 ETFs are incredibly efficient, often charging expense ratios as low as 0.03%. While buying individual UNH shares incurs no ongoing expense ratio, managing a portfolio of individual stocks can lead to higher transaction costs and less tax efficiency if you are actively trading to rebalance, compared to the internal, tax-free rebalancing of an ETF.

Bull Case

The bullish argument for UnitedHealth Group in July 2026 centers on its massive scale, improving margins, and aggressive shareholder returns.

  • Earnings Momentum: UNH reported a blowout second quarter in July 2026, with adjusted EPS surging 56% year-over-year to $6.38, crushing consensus estimates of $4.91 [2].
  • Improving Margins: A critical metric for health insurers is the medical cost ratio. UNH successfully drove this down to 86.7% in Q2 2026, a significant improvement from 89.4% in the prior-year period [2].
  • Shareholder Yield: The company is aggressively buying back its own stock, expecting to execute at least $5 billion in share repurchases in 2026, having already deployed $4 billion by mid-July [4]. Combined with a 3.0% dividend yield [3], the total shareholder return profile is highly attractive.

Bear Case

The bear case for UNH revolves around regulatory headwinds and valuation premiums.

  • Medicare Star Ratings: The most significant dark cloud over UNH is the deterioration in its 2027 Medicare Star Ratings, published by the CMS. This downgrade is projected to create a massive $1.5 billion revenue headwind in 2028 due to lost quality bonus payments [4].
  • Valuation: Despite the forward multiple looking reasonable, a trailing P/E of 31.9 [10] means the stock is priced for perfection. Any slip in execution or unexpected spikes in medical utilization could trigger a severe multiple compression.

Key Metrics Summary

MetricUnitedHealth Group (UNH)S&P 500 (SPY/VOO)
Current Price / Level~$418.00 [9]~5,500+
2026 YTD Return (July)+26.5% [10]+11% to +13% [4, 10]
2025 Return-33% [4]+16% [3]
Dividend Yield3.0% [3]~1.3%
Forward P/E23.22 [9]~21.0
Max Drawdown (Recent)-72% (Historical) [10]-25% (2022) [3]
DiversificationSingle Company (Healthcare)500 U.S. Large-Cap Companies

Frequently Asked Questions

Why did UNH stock drop so much in 2025?

UNH experienced a severe 33% decline in 2025 [4]. This was driven by a combination of rising medical cost ratios, broader sector rotations, and a specific 23% plunge in May 2025 that heavily impacted price-weighted indices like the Dow Jones [6].

How does UNH's dividend compare to the S&P 500?

UNH currently offers a dividend yield of roughly 3.0% [3], which is significantly higher than the S&P 500's average yield of around 1.3%. Furthermore, UNH has a strong track record of growing its dividend annually, supported by a 6.6% free cash flow yield [3].

Will the Medicare Star Ratings downgrade ruin UNH's profitability?

While the 2027 Medicare Star Ratings deterioration is a serious issue—projected to cause a $1.5 billion revenue headwind in 2028 [4]—it is important to contextualize this against UNH's massive scale. With LTM revenues approaching $450 billion [1], a $1.5 billion hit represents less than 0.5% of total revenue. It is a headwind, but not an existential threat.

Final Verdict

Is UNH a better investment than the S&P 500? For the vast majority of investors, No. The S&P 500 remains the superior choice for core portfolio holdings due to its unmatched diversification, lower volatility, and consistent compounding. The S&P 500 protects investors from the severe single-stock drawdowns that UNH has exhibited, such as its 33% drop in 2025 [4].

However, for active investors looking to generate alpha or increase their portfolio's dividend yield, UNH is a highly attractive satellite position. Following its strong Q2 2026 earnings beat and improving medical cost ratios [2], the stock has regained its footing. If you have a long time horizon and can stomach the regulatory volatility inherent to the healthcare sector, buying UNH at a forward P/E of 23.22 [9] offers a compelling entry point into one of the world's most dominant healthcare enterprises.

Ready to Analyze Your Next Investment?

Get a free AI-powered fair value analysis on any stock. See intrinsic value, margin of safety, and institutional-grade risk metrics in seconds. No credit card required.

Want full access to our institutional research tools? Explore Invest Daily Pro.

Put This Into Practice

You're learning technical analysis. See how AI reads a live chart right now.

Upload any stock chart or enter a ticker and our AI identifies key patterns, support/resistance levels, trend strength, and flags potential entry/exit zones.

Watch: Related Videos

from Invest Daily
Watch: I Built an AI That Values Any Stock in 30 Seconds (Full Demo)
YouTube
Watch: $3 TRILLION Gone in One Day… What Happens to Stocks This Week?
YouTube

Get This Analysis in Your Inbox Every Morning

Get our daily market briefing with institutional-grade analysis, key developments, and actionable strategy - delivered before the opening bell.